Key Takeaways Regarding Use of 45 Gy Novel Radiotherapy in CNS Cancers
Rupesh Kotecha, MD, discusses the key findings from an analysis centered around the use of pulse reduced dose rate intensity-modulated radiotherapy in patients with central nervous system malignancies.
Kotecha Analyzes Use of 45 Gy Novel Radiotherapy in CNS Cancers
Rupesh Kotecha, MD, discusses results of an analysis which centered around the use of pulse reduced dose rate intensity-modulated radiotherapy in patients with central nervous system malignancies.